Genomics England – The Generation Study – CAH included
The Generation Study is being carried out by Genomics England in partnership with the NHS. It is exploring the possible use of genome sequencing in newborn babies to identify a wide range of rare genetic conditions alongside the routine newborn blood spot screening. The study will include 100,000 newborns and the first participants are expected to join the study in the next few weeks.
As part of the study, Genomics England have created a list of rare conditions and associated genes that they will be looking for – and CAH is included. These conditions are chosen by following four key principles.
An extract of the list showing the types of CAH which are included is below:
| Condition Group | Gene | Condition name |
| Congenital adrenal hyperplasia | CYP17A1 | 17-alpha-hydroxylase/17,20-lyase deficiency |
| Congenital adrenal hyperplasia | CYP21A2 *This gene meets the principles to be included, however it is not currently being analysed due to further internal work being required | Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
| Congenital adrenal hyperplasia | CYP11B1 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency |
| Congenital adrenal hyperplasia | HSD3B2 | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
The list is being kept under constant review throughout the study and is subject to change as new evidence emerges. Genomics England is working with the NHS in England to ensure availability of treatments and to confirm that the genome sequencing technology used in the study can reliably identify changes in the genes causing these conditions.
The results of the study will add to evidence that will inform future decisions on using whole genome sequencing to support newborn screening. This includes using it to accelerate diagnosis and access to treatments for rare conditions.
More information
Genomics England homepage – https://www.genomicsengland.co.uk/
The Generation Study – https://www.genomicsengland.co.uk/initiatives/newborns
Recent Blog Posts
Webinar: Quality of life and fertility in CAH – 21st November 2026
The European Society for Endocrinology (ESE) is running a free webinar focussing on CAH on 21st November 2026. Hear from patients and clinicians from across Europe as the subjects of health-related quality of life and preserving fertility across the lifespan are...
Supporting Safer Adrenal Crisis Care
The Addison’s Disease Self-Help Group (ADSHG) has launched a national advocacy campaign to improve emergency treatment and patient safety for people at risk of adrenal crisis. The campaign was sparked by the discontinuation of liquid hydrocortisone in the UK, which...
Pituitary Awareness Month (October) – Symptoms in the Spotlight
October is Pituitary Awareness Month. Although not CAH, some of the information from the Pituitary Foundation may be helpful for those living with CAH. Find out more at the Pituitary Foundation's website here. Header image from Pituitary Foundation UK. Recent Blog...